NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
5.80
+0.21 (3.76%)
At close: Oct 19, 2026, 4:00 PM EDT
5.79
-0.01 (-0.17%)
After-hours: Oct 19, 2026, 7:36 PM EDT
NEXGEL Revenue
NEXGEL had revenue of $3.69M in the quarter ending June 30, 2026, with 27.81% growth. This brings the company's total for the last twelve months to $12.07M, up 3.38% year-over-year. In the year 2025, NEXGEL had annual revenue of $11.42M with 31.46% growth. That makes NEXGEL the 36,457th largest company in the world by revenue and 4,795th in the United States.
Revenue (ttm)
$12.07M
Revenue Growth
+3.38%
P/S Ratio
0.23
Revenue / Employee
$635,105
Employees
19
Market Cap
2.83M
Revenue by Segment
- Nexgel 8.61M 75.4%
- CGN JV 2.81M 24.6%
Fiscal year ended Dec 31, 2025 See the full NEXGEL breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.42M | 2.73M | 31.46% |
| Dec 31, 2024 | 8.69M | 4.60M | 112.47% |
| Dec 31, 2023 | 4.09M | 2.04M | 99.66% |
| Dec 31, 2022 | 2.05M | 497.00K | 32.04% |
| Dec 31, 2021 | 1.55M | 877.00K | 130.12% |
| Dec 31, 2020 | 674.00K | -43.00K | -6.00% |
| Dec 31, 2019 | 717.00K | -1.50M | -67.60% |
| Dec 31, 2018 | 2.21M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| Retractable Technologies | 33.90M |
| Precision Optics Corporation | 31.53M |
| Bionano Genomics | 30.18M |
| Nephros | 20.72M |
| Milestone Scientific | 9.42M |
| Lucyd | 3.41M |
| Femasys | 2.30M |
NXGL News
- 10 days ago - Nexgel Inc trading halted, news pending - TheFly
- 25 days ago - NEXGEL Transcript: Investor update - Transcripts
- 25 days ago - NEXGEL Slides: Investor update - Filings
- 26 days ago - NEXGEL Announces Dial-In Details for Investor Update Call - GlobeNewsWire
- 4 weeks ago - NEXGEL Announces Date for Investor Update Call - GlobeNewsWire
- 1 month ago - NexGel downgraded to Hold from Buy at Maxim - TheFly
- 1 month ago - NexGel downgraded to Hold from Buy at Maxim - TheFly
- 1 month ago - NEXGEL Proxy statement: Proxy filing - Filings